Towa Pharmaceutical Co., Ltd. (TWAPF)
25.98
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Towa Pharmaceutical EPS Diluted (Quarterly) : 0.7051 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7051 |
| March 31, 2026 | -1.532 |
| December 31, 2025 | 1.169 |
| September 30, 2025 | 0.7855 |
| June 30, 2025 | 0.3531 |
| March 31, 2025 | 0.5814 |
| December 31, 2024 | 1.076 |
| September 30, 2024 | 0.1443 |
| June 30, 2024 | 0.7164 |
| March 31, 2024 | 0.637 |
| December 31, 2023 | 0.6271 |
| September 30, 2023 | 0.3096 |
| June 30, 2023 | 0.7017 |
| March 31, 2023 | 0.0258 |
| December 31, 2022 | -0.1017 |
| September 30, 2022 | 0.1905 |
| June 30, 2022 | 0.2105 |
| March 31, 2022 | 0.1559 |
| December 31, 2021 | 1.006 |
| September 30, 2021 | 0.7256 |
| June 30, 2021 | 0.9647 |
| March 31, 2021 | 0.7958 |
| December 31, 2020 | 0.6079 |
| September 30, 2020 | 0.5828 |
| June 30, 2020 | 0.5831 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6095 |
| December 31, 2019 | 0.6749 |
| September 30, 2019 | 0.5782 |
| June 30, 2019 | 0.6438 |
| March 31, 2019 | 0.5153 |
| December 31, 2018 | 0.7132 |
| September 30, 2018 | 0.4402 |
| June 30, 2018 | 0.6143 |
| March 31, 2018 | -0.1648 |
| December 31, 2017 | 0.5111 |
| September 30, 2017 | 0.3892 |
| June 30, 2017 | 0.3391 |
| March 31, 2017 | 0.1275 |
| December 31, 2016 | 0.8102 |
| September 30, 2016 | 0.2333 |
| June 30, 2016 | -0.207 |
| March 31, 2016 | 0.2233 |
| December 31, 2015 | 0.3547 |
| September 30, 2015 | 0.2678 |
| June 30, 2015 | 0.3618 |
| March 31, 2015 | 0.3642 |
| December 31, 2014 | 0.829 |
| September 30, 2014 | 0.5255 |
| June 30, 2014 | 0.2463 |
| March 31, 2014 | 0.1628 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.2213 |
| Daiichi Sankyo Co., Ltd. | 0.2366 |
| Eisai Co., Ltd. | 0.1015 |
| Chugai Pharmaceutical Co., Ltd. | 0.2218 |
| Santen Pharmaceutical Co., Ltd. | 0.1399 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 34.71M |
| Revenue (Quarterly) | 447.93M |
| Total Expenses (Quarterly) | 413.23M |
| Enterprise Value | 2.434B |
| Gross Profit Margin (Quarterly) | 36.56% |
| Profit Margin (Quarterly) | 7.75% |
| Earnings Yield | 4.34% |
| Operating Earnings Yield | 12.37% |
| Normalized Earnings Yield | 6.614 |